Ph.D., economics, University of California, Berkeley; B.A., economics, the Johns Hopkins University
Summary of Experience
Dr. Mortimer specializes in health economics, microeconomic theory, and econometrics. He has provided economic analyses in numerous matters on behalf of clients in the pharmaceutical industry, with a focus on generic entry. His experience includes leading analyses of large data sets to assess market definition, determine liability, and calculate damages. He has also supported counsel on several government investigations related to marketing, physician payments, and pricing in the pharmaceutical and medical device industries. In these investigations, he has evaluated factors contributing to off-label drug use or medical device adoption, and has presented analyses to investigators, including appearing before the U.S. Attorney's Office. Outside of litigation, Dr. Mortimer has developed pricing analyses for pharmaceutical clients and collaborated with academics in authoring several public policy studies related to pharmaceutical and general health care legislation. Dr. Mortimer has published several articles in leading peer-reviewed health economics and industrial organization journals, including Health Affairs, Nature Reviews Drug Discovery, the Journal of Medical Economics, and The Journal of Industrial Economics.